Coronado Biosciences Announces Departure of Dr. Bobby W. Sandage, Jr.

Published: Apr 24, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BURLINGTON, Mass., April 24, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today the departure of Dr. Bobby W. Sandage, Jr., President and Director of the Company, to pursue other interests. Dr. Sandage served as President and Chief Executive Officer and Director from March 2011 through December 2012, and as President and Director from January 2013 until his departure.

Help employers find you! Check out all the jobs and post your resume.

Back to news